
Matthew Hammond
Partner · RA Capital Management
PartnerBoston, MA
Matthew Hammond is a Partner at RA Capital working across public and private investments, and serves as a board director for Ambros Therapeutics. He previously served as a director of DTx Pharma, Emergence Therapeutics, Forge Biologics and Jnana Therapeutics, each until its acquisition. He holds a Ph.D. in biomedical science and an MBA from the University of Connecticut.
Board seats
51 current
· PUBLIC SOURCES
Credited hits
4
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Matthew Hammond, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- DTx Pharmaacquired
Acquired by Novartis; Hammond served as a director prior to the acquisition, per RA Capital team page.
- Emergence Therapeuticsacquired
Acquired by Eli Lilly; Hammond served as a director prior to the acquisition, per RA Capital team page.
- Forge Biologicsacquired
Acquired by Ajinomoto; Hammond served as a director prior to the acquisition, per RA Capital team page.
- Jnana Therapeuticsacquired
Acquired by Otsuka; Hammond served as a director prior to the acquisition, per RA Capital team page.
Board seats
Current board seats · 1
- Ambros TherapeuticsSource: ra-capital-prod.azurewebsites.net
Former board seats · 4
- DTx PharmaSource: ra-capital-prod.azurewebsites.net
- Emergence TherapeuticsSource: ra-capital-prod.azurewebsites.net
- Forge BiologicsSource: ra-capital-prod.azurewebsites.net
- Jnana TherapeuticsSource: ra-capital-prod.azurewebsites.net
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
No reputation sources on file yet.
Suggest a sourceContact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- www.racap.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Matthew Hammond. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Matthew Hammond.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Matthew Hammond — provenance: GlassVC catalog
↩ cites: Title · Firm · Type · Bio · Location · Credited deals · Board seats
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
